Evidence map›Paper›PMID 28082109›Full record

ArticleToxicology2017

1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice.

Jessica H Hartman, Grover P Miller, Andres A Caro, Stephanie D Byrum, Lisa M Orr, Samuel G Mackintosh, Alan J Tackett, Lee Ann MacMillan-Crow, Lance M Hallberg, Bill T Ameredes and 1 more

Abstract read
In one paragraph

Article in Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Multifarious Link between Cytochrome P450s and Cancer.Oxidative medicine and cellular longevity · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jessica H HartmanDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Grover P MillerDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Electronic address: MillerGroverP@uams.edu.
Andres A CaroDepartment of Chemistry, Hendrix College, Conway, AR, United States.
Stephanie D ByrumDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Lisa M OrrDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Samuel G MackintoshDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Alan J TackettDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Lee Ann MacMillan-CrowPharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Lance M HallbergDepartment of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX, United States; Sealy Center for Environmental Health and Medicine, University of Texas Medical Branch, Galveston, TX, United States.
Bill T AmeredesSealy Center for Environmental Health and Medicine, University of Texas Medical Branch, Galveston, TX, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, and Department of Pharmacology and Toxicology, United States.
Gunnar BoysenDepartment of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States; The Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Electronic address: gboysen@uams.edu.
University of Arkansas for Medical Sciences · USHendrix College · USPulmonary and Critical Care Associates · USThe University of Texas Medical Branch at Galveston · USWinthrop Rockefeller Foundation · US

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2012 to 2026
$60.9M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Samrat Roy Choudhury · 2017 to 2026
$27.6M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Epigenetic profiling and enzymatic regulation of H3K23me3 during cellular differentiationR01GM118760 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI TAVERNA, SEAN D. · 2017 to 2020
$1.5M
Using ChAP-MS to Study Macromolecular Chromatin Composition during TranscriptionR01GM106024 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI TACKETT, ALAN, TAVERNA, SEAN D. · 2013 to 2016
$1.2M
Orbitrap Fusion Tribrid Mass SpectrometerS10OD018445 · OD · UNIV OF ARKANSAS FOR MED SCIS · PI MACKINTOSH, SAMUEL G. · 2015 to 2015
$856k
Identifying the epigenetic regulation of arsenic exposure - Revision 2R21ES025268 · NIEHS · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN · 2015 to 2017
$487k
Effects of Genetic Diversity on Carcinogen MetabolismR21ES023046 · NIEHS · UNIV OF ARKANSAS FOR MED SCIS · PI BOYSEN, GUNNAR · 2014 to 2015
$425k
Technology for Identification of Epiproteomes in Tissue SamplesR21DA041822 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN · 2016 to 2017
$373k
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven NeurodegenerationF32ES027306 · NIEHS · DUKE UNIVERSITY · PI HARTMAN, JESSICA HELENE · 2016 to 2018
$171k
NCATS NIH HHS UL1 TR000039NIDA NIH HHS R21 DA041822NIEHS NIH HHS F32 ES027306NIEHS NIH HHS P30 ES006676NIEHS NIH HHS R21 ES023046NIEHS NIH HHS R21 ES025268NIGMS NIH HHS P20 GM103429NIGMS NIH HHS P20 GM103625NIGMS NIH HHS P20 GM121293NIGMS NIH HHS R01 GM106024NIGMS NIH HHS R01 GM118760NIH HHS S10 OD018445
6 · The paper itself

Abstract

Cytochrome P450 2E1 (CYP2E1) metabolizes low molecular weight hydrophobic compounds, including 1,3-butadiene, which is converted by CYP2E1 to electrophilic epoxide metabolites that covalently modify cellular proteins and DNA. Previous CYP2E1 studies have mainly focused on the enzyme localized in the endoplasmic reticulum (erCYP2E1); however, active CYP2E1 has also been found in mitochondria (mtCYP2E1) and the distribution of CYP2E1 between organelles can influence an individual's response to exposure. Relatively few studies have focused on the contribution of mtCYP2E1 to activation of chemical toxicants. We hypothesized that CYP2E1 bioactivation of 1,3-butadiene within mitochondria adversely affects mitochondrial respiratory complexes I-IV. A population of Collaborative Cross mice was exposed to air (control) or 200ppm 1,3-butadiene. Subcellular fractions (mitochondria, DNA, and microsomes) were collected from frozen livers and CYP2E1 activity was measured in microsomes and mitochondria. Individual activities of mitochondrial respiratory complexes I-IV were measured using in vitro assays and purified mitochondrial fractions. In air- and 1,3-butadiene-exposed mouse samples, mtDNA copy numbers were assessed by RT-PCR, and mtDNA integrity was assessed through a PCR-based assay. No significant changes in mtDNA copy number or integrity were observed; however, there was a decrease in overall activity of mitochondrial respiratory complexes I, II, and IV after 1,3-butadiene exposure. Additionally, higher mtCYP2E1 (but not erCYP2E1) activity was correlated with decreased mitochondrial respiratory complex activity (in complexes I-IV) in the 1,3-butadiene-exposed (not control) animals. Together, these results represent the first in vivo link between mitochondrial CYP2E1 activity and mitochondrial toxicity.

Indexed as

AnimalsButadienesCarcinogensCytochrome P-450 CYP2E1DNA Copy Number VariationsDNA, MitochondrialElectron Transport Complex IElectron Transport Complex IIIElectron Transport Complex IVFemaleMiceMitochondria, LiverSuccinate Dehydrogenase1,3-butadieneButadienesCarcinogenscytochrome P-450 2E1, mouseCytochrome P-450 CYP2E1DNA, MitochondrialElectron Transport Complex IElectron Transport Complex IIIElectron Transport Complex IVSuccinate Dehydrogenase1,3-ButadieneCollaborative CrossCYP2E1Mitchondrial function

Identifiers

PMID28082109
PMCPMC5319481
OpenAlexW2570427039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.